ProMIS Neurosciences, Inc. (PMN)
12.30
+0.25
(+2.07%)
USD |
NASDAQ |
Apr 15, 16:00
12.20
-0.10
(-0.81%)
Pre-Market: 20:00
ProMIS Neurosciences Total Assets (Quarterly) : 9.182M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 7.582M |
| Aurinia Pharmaceuticals, Inc. | 770.59M |
| Edesa Biotech, Inc. | 14.71M |
| Lexaria Bioscience Corp. | 6.487M |
| Xenon Pharmaceuticals, Inc. | 981.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.44M |
| Shareholders Equity (Quarterly) | -1.259M |
| Current Ratio | 0.8788 |